Personnel

Pharma firm selects Martyn D. Greenacre as chairman

Published in Drug Week, December 31st, 2004

Beijing Med-Pharm (BJGP) announced that Martyn D. Greenacre has been named chairman, replacing Peter Coker who continues to serve as a director.

Greenacre, a seasoned pharmaceutical executive, will advance the company's capacity to deliver a complete solution to U.S. and European pharmaceutical firms interested in entering the Chinese marketplace.

Greenacre currently serves as a director of Acusphere, Inc., (ACUS); Cephalon, Inc., (CEPH); Curis, Inc., (CRIS); and Immune Response Corp. (IMNR).

Greenacre began his pharmaceutical career with SmithKline & French Laboratories (now part of GlaxoSmithKline PLC), where he was responsible...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2004-12-31)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry